AI Accelerating Drug Discovery Using DEL ( DNA Encoded Libraries) For Data Generation with Citadel

Rohit Mahajan, Co-Founder and President, Citadel Discovery and Managing Partner BigRio, Citadel Discovery

Abstract:
AI has the potential to accelerate the drug discovery process so that cures for diseases can be found faster. The current 10 year cycle, costing $5B needs disruption. Citadel Discovery is leading the way in the small molecule drug discovery using AI and DNA Encoded Libraries for generating very large data sets.